Literature DB >> 11287184

Involvement of EphA2 in the formation of the tail notochord via interaction with ephrinA1.

C Naruse-Nakajima1, M Asano, Y Iwakura.   

Abstract

Eph receptors have been implicated in cell-to-cell interaction during embryogenesis. We generated EphA2 mutant mice using a gene trap method. Homozygous mutant mice developed short and kinky tails. In situ hybridization using a Brachyury probe found the notochord to be abnormally bifurcated at the caudal end between 11.5 and 12.5 days post coitum. EphA2 was expressed at the tip of the tail notochord, while one of its ligands, ephrinA1, was at the tail bud in normal mice. In contrast, EphA2-deficient notochordal cells were spread broadly into the tail bud. These observations suggest that EphA2 and its ligands are involved in the positioning of the tail notochord through repulsive signals between cells expressing these molecules on the surface.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11287184     DOI: 10.1016/s0925-4773(01)00290-8

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  19 in total

1.  The zebrafish tailbud contains two independent populations of midline progenitor cells that maintain long-term germ layer plasticity and differentiate in response to local signaling cues.

Authors:  Richard H Row; Steve R Tsotras; Hana Goto; Benjamin L Martin
Journal:  Development       Date:  2015-12-16       Impact factor: 6.868

2.  Bidirectional signaling through ephrinA2-EphA2 enhances osteoclastogenesis and suppresses osteoblastogenesis.

Authors:  Naoko Irie; Yasunari Takada; Yoshihiko Watanabe; Yumi Matsuzaki; Chie Naruse; Masahide Asano; Yoichiro Iwakura; Toshio Suda; Koichi Matsuo
Journal:  J Biol Chem       Date:  2009-03-19       Impact factor: 5.157

3.  High expression of EphB6 protein in tongue squamous cell carcinoma is associated with a poor outcome.

Authors:  Yingchun Dong; Jicheng Pan; Yanhong Ni; Xiaofeng Huang; Xiao Chen; Jiandong Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

4.  Update on the cytogenetics and molecular genetics of chordoma.

Authors:  Lidia Larizza; Pietro Mortini; Paola Riva
Journal:  Hered Cancer Clin Pract       Date:  2005-02-15       Impact factor: 2.857

5.  EphA2 is an essential mediator of UV radiation-induced apoptosis.

Authors:  Guoqi Zhang; Ching-Ni Njauw; Jong Min Park; Chie Naruse; Masahide Asano; Hensin Tsao
Journal:  Cancer Res       Date:  2008-03-15       Impact factor: 12.701

Review 6.  Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer.

Authors:  Michael S Kinch; Kelly Carles-Kinch
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

7.  Eph regulates dorsoventral asymmetry of the notochord plate and convergent extension-mediated notochord formation.

Authors:  Izumi Oda-Ishii; Yasuo Ishii; Takashi Mikawa
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

8.  Ligand targeting of EphA2 enhances keratinocyte adhesion and differentiation via desmoglein 1.

Authors:  Samantha Lin; Kristin Gordon; Nihal Kaplan; Spiro Getsios
Journal:  Mol Biol Cell       Date:  2010-09-22       Impact factor: 4.138

9.  EPHA2 is associated with age-related cortical cataract in mice and humans.

Authors:  Gyungah Jun; Hong Guo; Barbara E K Klein; Ronald Klein; Jie Jin Wang; Paul Mitchell; Hui Miao; Kristine E Lee; Tripti Joshi; Matthias Buck; Preeti Chugha; David Bardenstein; Alison P Klein; Joan E Bailey-Wilson; Xiaohua Gong; Tim D Spector; Toby Andrew; Christopher J Hammond; Robert C Elston; Sudha K Iyengar; Bingcheng Wang
Journal:  PLoS Genet       Date:  2009-07-31       Impact factor: 5.917

10.  Evidence that the EphA2 receptor exacerbates ischemic brain injury.

Authors:  John Thundyil; Silvia Manzanero; Dale Pavlovski; Tanya R Cully; Ker-Zhing Lok; Alexander Widiapradja; Prasad Chunduri; Dong-Gyu Jo; Chie Naruse; Masahide Asano; Bradley S Launikonis; Christopher G Sobey; Mark G Coulthard; Thiruma V Arumugam
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.